SYRA Stock Overview
A healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Syra Health Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.38 |
| 52 Week High | US$8.37 |
| 52 Week Low | US$0.34 |
| Beta | 0 |
| 1 Month Change | 3.85% |
| 3 Month Change | -13.73% |
| 1 Year Change | -63.46% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -87.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| SYRA | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -8.8% | -4.1% | -2.4% |
| 1Y | -63.5% | -10.2% | 23.4% |
Return vs Industry: SYRA underperformed the US Healthcare industry which returned -10.2% over the past year.
Return vs Market: SYRA underperformed the US Market which returned 23.4% over the past year.
Price Volatility
| SYRA volatility | |
|---|---|
| SYRA Average Weekly Movement | 12.3% |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: SYRA's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: SYRA's weekly volatility has decreased from 51% to 12% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 120 | Deepika Vuppalanchi | www.syrahealth.com |
Syra Health Corp., a healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce in the United States. The company Syrenity, behavioral and mental health application that identifies and prevents the progression of negative factors that can influence individuals’ mental health, by offering targeted assignments, education, monitoring symptoms, and providing interventions; digital health products, such as SyraBot that automates manual tasks to streamline healthcare professional care, aiding patients in identifying health warning signs, encouraging therapy and medical regimens, and space for patients to share personal information; and CarePlus, a customizable templates, e-prescribing, laboratory integration, and patient portal access. It offers analytics as a service which includes data collection, traditional to advanced analytics, predictive analytics, risk stratification, intervention analytics, spatial analytics gap analysis, analytics workforce public policy, and research; epidemiology, and health equity analytics solutions.
Syra Health Corp. Fundamentals Summary
| SYRA fundamental statistics | |
|---|---|
| Market cap | US$6.58m |
| Earnings (TTM) | -US$4.25m |
| Revenue (TTM) | US$7.74m |
0.8x
P/S Ratio-1.5x
P/E RatioIs SYRA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SYRA income statement (TTM) | |
|---|---|
| Revenue | US$7.74m |
| Cost of Revenue | US$5.97m |
| Gross Profit | US$1.78m |
| Other Expenses | US$6.03m |
| Earnings | -US$4.25m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.25 |
| Gross Margin | 22.94% |
| Net Profit Margin | -54.90% |
| Debt/Equity Ratio | 7.2% |
How did SYRA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 18:28 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Syra Health Corp. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Marla Marin | Zacks Small-Cap Research |